HealthcareServices

Global Blood Screening Market Performance Report: Global Trends 2026–2030

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the blood screening market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Blood Screening Market reach by 2030 starting from 2026 levels?

The blood screening market size has observed rapid expansion in recent years. It is projected to increase from $3.44 billion in 2025 to $3.84 billion in 2026, registering a compound annual growth rate (CAGR) of 11.6%. The historical growth in this market can be attributed to factors like the rise in regulatory screening requirements, an expansion in blood donation volumes, an increase in the prevalence of transfusion-transmitted infections, the development of centralized blood banks, and the adoption of ELISA-based testing.

The blood screening market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $5.93 billion, exhibiting a compound annual growth rate (CAGR) of 11.5%. This anticipated growth during the forecast period is primarily driven by heightened investments in cutting-edge screening technologies, a surging need for swift and precise diagnostic tools, the wider acceptance of molecular testing, the increasing incorporation of AI-powered data analysis, and a stronger emphasis on worldwide blood safety regulations. Key trends expected over this period encompass the escalating embrace of nucleic acid testing technologies, a growing requirement for high-throughput screening systems, the expanding utilization of automated blood screening instruments, the proliferation of software-integrated screening platforms, and an intensified commitment to ensuring transfusion safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Drivers Are Influencing Long-Term Growth In The Blood Screening Market?

The growing incidence of chronic diseases is projected to stimulate expansion in the blood screening market. Chronic diseases are long-lasting conditions or ailments that are generally manageable but not curable, demanding adjustment to both the therapy employed and its requirements. During transfusions, blood screening meticulously verifies the compatibility between the donor’s and recipient’s blood types. Blood transfusions are frequently a necessary component of medical interventions for various chronic illnesses, including autoimmune diseases, hematological disorders, and all forms of cancer. For example, in September 2023, the World Health Organization, a specialized United Nations agency situated in Switzerland, reported that 41 million deaths globally each year, accounting for 74% of total fatalities, were attributable to non-communicable diseases (NCDs) or chronic diseases. Hence, the rising occurrence of chronic diseases is propelling the growth of the blood screening market.

Which Segments Are Driving Activity In The Blood Screening Market?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Which Market Trends Are Opening Growth Opportunities In The Blood Screening Market?

Major companies in the blood screening market are advancing technologies such as liquid biopsy to improve early cancer detection, enhance treatment monitoring, and enable personalized medicine approaches. A liquid biopsy is a non-invasive procedure that examines blood or other bodily fluids to identify cancer cells or genetic material originating from tumors. For instance, in November 2023, Guardant Health, Inc., a US-based biotechnology company, introduced Shield blood-based screening tests. The Shield test evaluates cell-free DNA (cfDNA) circulating in the bloodstream, which can signal the existence of colorectal tumors or precancerous formations. It specifically seeks out alterations in DNA fragments that cancer cells release into the blood.

Which Leading Companies Dominate The Blood Screening Market Share?

Major companies operating in the blood screening market are Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Cepheid Inc., Haemonetics Corporation, Verax Biomedical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

How Does The Blood Screening Market Perform Across Major Global Regions?

North America was the largest region in the blood screening market in 2025. The regions covered in the blood screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Blood Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Browse Through More Reports Similar to the Global Blood Screening Market 2026, By The Business Research Company

Bleeding Disorder Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Drug Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Blood Culture Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795